The BHF claims women are less likely than men to seek medical attention when experiencing a cardiac episode.

The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...

The trial aims to enrol 87 subjects with low-grade intermediate-risk non-muscle invasive bladder cancer. Credit: Antonio Marca/Shutterstock. UroGen Pharma has announced the dosing of the first subject ...

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, mRNA-1403.

ProPharma is a global research consulting company and a Dual-Category Award Winner in the 2024 Clinical Trials Arena Excellence Awards. ProPharma, a global research consulting company headquartered in ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

The PALIZADE trial aims to assess the efficacy and safety of zetomipzomib in active lupus nephritis patients. Credit: Sebastian Kaulitzki / Shutterstock. US-based biopharmaceutical company Kezar Life ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.